65 filings
8-K
IDYA
Ideaya Biosciences Inc
12 Mar 24
IDEAYA Announces Clinical Collaboration to Evaluate IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer
6:04am
8-K
IDYA
Ideaya Biosciences Inc
20 Feb 24
IDEAYA Biosciences, Inc. Reports Fourth Quarter and Full-Year 2023
6:07am
8-K
IDYA
Ideaya Biosciences Inc
23 Jan 24
Other Events
6:03am
8-K
IDYA
Ideaya Biosciences Inc
19 Jan 24
Entry into a Material Definitive Agreement
5:18pm
8-K
IDYA
Ideaya Biosciences Inc
16 Jan 24
Other Events
6:07am
8-K
ndm066rjakmk mjndo
12 Jan 24
Other Events
6:04am
8-K
w2f8eef1
4 Dec 23
IDEAYA Announces Clinical Study Collaboration with Gilead Sciences to Evaluate Trodelvy® and IDE397 Combination in MTAP-Deletion Bladder Cancer
6:04am
8-K
l7bqew6ppn5npxjayn1
17 Nov 23
Entry into a Material Definitive Agreement
6:02am
8-K
f7yt 1jgoc1m8nfhlj
7 Nov 23
IDEAYA Biosciences, Inc. Reports Third Quarter 2023
6:01am
8-K
wjf73t92bjlqtjj2 rc
27 Oct 23
Other Events
4:23pm
8-K
11zw4ryrf8k9rar
24 Oct 23
Results of Operations and Financial Condition
4:21pm
8-K
1pf wjbdw
23 Oct 23
Other Events
8:09am
8-K
t9dk5
26 Sep 23
Departure of Directors or Certain Officers
6:05am
8-K
sg19grsvj7
10 Aug 23
IDEAYA Biosciences, Inc. Reports Second Quarter 2023
6:01am
8-K
525lo3 9vl47kgtq1wlh
3 Jul 23
Departure of Directors or Certain Officers
4:01pm
8-K
msfbwz
30 Jun 23
Entry into a Material Definitive Agreement
4:01pm
8-K
ubtc4n 4mwrhe5zxpv
9 Jun 23
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
4zi3ss gaui
6 Jun 23
Entry into a Material Definitive Agreement
6:02am
8-K
pat3u hgn7b1
16 May 23
IDEAYA Expands Clinical Trial Collaboration and Supply Agreements with Pfizer
6:02am
8-K
f3l 7aq3scwdxe
9 May 23
IDEAYA Biosciences, Inc. Reports First Quarter 2023 Financial Results
6:01am